The 3rd Swedish Meeting for Alzheimer Research, April 10, 2025

9.30  Dean KI North Carl Johan Sundberg

9.35  H.M. Drottning Silvia

9.42  Director of Center for Alzheimer Research (CAR) Daniel Ferreira 

Chairs: Lars Lannfelt (UU) and Sara Hägg (KI)

Speakers:
Giulia Grande (KI-ARC), “Blood biomarkers of Alzheimer´s disease and dementia in the community”
Karolina Kauppi (UmU): “Influence of pathway-based polygenic risk scores for Alzheimer’s Disease on dementia risk and age-related cognitive decline”
Sara Hägg (KI), “Biological aging and the risk for Alzheimer’s disease and related dementias”
Nicholas Levak (GOLD SPONSOR – NUTRICIA): “Latest research on medical nutrition interventions in early AD”

Chairs: Anna Månberg (KTH) and Hugo Lövheim (UmU)

Speakers:
Axel Abelein (KI), “Identification of potential aggregation hotspots on aβ42 fibrils blocked by the   anti-amyloid chaperone-like brichos domain”
Sofie Nyström (LiU), “Virus amyloid – a link between virus infection and Alzheimer’s disease?”
Dag Sehlin(UU), “Structural features of Aβ aggregates with the Uppsala deletion”
Daniel Jaraj (GOLD SPONSOR – ELI LILLY): “Eli Lilly's commitment to Alzheimer's research: Advancing progress through innovation and care”

Chair: Per Nilsson (KI)

12.35 – 12.45 LUNCH PRESENTATION FROM SILVER SPONSORS. 
Chair: Daniel Ferreira

Canan Ugur Yilmaz (SILVER SPONSOR – QUANTERIX): “Simoa® technology: Unlocking new insights in Alzheimer's disease through ultrasensitive biomarker detection”

Chairs: Jakob Vogel (LU) and Sara Pudas (UmU)

Speakers:
Laia Montoliu-Gaya, “Next challenges in blood biomarkers for Alzheimer’s disease”
Ruben Smith (LU), “Clinical value of tau PET imaging and tau PET/tau pathology correlations”
Rodrigo Moreno (KTH), “Synthetic MRI aging”
Anne-Li Lind (GOLD SPONSOR – OLINK): “Advancing neurodegeneration research through proteomics”

Liselotte Jansson (Alzheimerfonden, Secretary General), “A presentation of the Swedish Alzheimerfoundation”

Sophia Du Rietz (Alzheimerfonden, Marketing Manager) “A conversation with an Alzheimer's patient and a relative”

Chairs: Maria Lindskog (UU) and Tomas Deierborg (LU)

Speakers:
Anna Erlandsson (UU), “Astrocytes: a potential target to reduce cell-to-cell spreading in Alzheimer’s disease”
Henrietta Nielsen (SU), “APOE and systemic processes”
Malin Wennström (LU) "The retina-brain nexus: Implications in Alzheimer’s disease” 
Petronella Kettunen (GU), ”Neuroinflammatory markers differ from controls and correlate with vascular  pathologies and cognition in patients with manifest dementia”

Chairs: Helena Karlström (KI) and Dorota Religa (KI)

Speakers:
Linus Jönsson (KI-NG), “How much should we be prepared to pay for disease-modifying treatments in           Alzheimer’s disease?”
Dorota Religa (KI-CG), ”Swedish registry for cognitive/dementia disorders, SveDem - development of Drug module for real life data” 
Greta Hultqvist (UU), “Enhanced endogenous degradation of amyloid beta as a treatment strategy for  Alzheimer's disease: utilizing gene and protein therapy”
Per-Ola Freskgård (GOLD SPONSOR – BIOARCTIC): “Brain delivery in Alzheimer's disease”

CAR Steering group: Chengxuan Qiu, Dorota Religa, Per Nilsson, Daniel Ferreira